Eye-preserving therapies for advanced retinoblastoma: a multicenter cohort of 1678 patients in China.
Sign Up to like & getrecommendations! Published in 2021 at "Ophthalmology"
DOI: 10.1016/j.ophtha.2021.09.002
Abstract: PURPOSE Multiple eye-preserving treatments have been widely used in China for the last 15 years, however, controversy remains on using eye-preserving therapies for advanced retinoblastoma (The International Intraocular Retinoblastoma Classification: groups D and E). This… read more here.
Keywords: advanced retinoblastoma; preserving therapies; eye preserving; overall survival ... See more keywords
Risk factors for cataract in retinoblastoma management
Sign Up to like & getrecommendations! Published in 2023 at "British Journal of Ophthalmology"
DOI: 10.1136/bjo-2022-321723
Abstract: Aims To investigate the risk factors for cataract following eye-preserving therapies for retinoblastoma. Methods This retrospective, single-centre cohort study included patients diagnosed with retinoblastoma receiving eye-preserving therapies between January 2017 and June 2021. Cataract by… read more here.
Keywords: eye preserving; risk factors; risk; factors cataract ... See more keywords